Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

Many breast cancer (BC) patients treated with aromatase inhibitors (AIs) develop aromatase inhibitor‐related arthralgia (AIA). Candidate gene studies to identify AIA risk are limited in scope. We evaluated the potential of a novel analytic algorithm (NAA) to predict AIA using germline single nucleot...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinbolt, Raquel E., Sonis, Stephen, Timmers, Cynthia D., Fernández‐Martínez, Juan Luis, Cernea, Ana, de Andrés‐Galiana, Enrique J., Hashemi, Sepehr, Miller, Karin, Pilarski, Robert, Lustberg, Maryam B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773952/
https://www.ncbi.nlm.nih.gov/pubmed/29168353
http://dx.doi.org/10.1002/cam4.1256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773952/
https://www.ncbi.nlm.nih.gov/pubmed/29168353
http://dx.doi.org/10.1002/cam4.1256

Ejemplares similares